Page last updated: 2024-10-31

nabumetone and Urticaria

nabumetone has been researched along with Urticaria in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Urticaria: A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perez-Ezquerra, PR1
Sanchez-Morillas, L1
Laguna Martinez, JJ1
Gonzalez Mendiola, R1
Gomez-Traseira, C1
Carrasco Garcia, I1
Herranz MaƱas, M1
Rubio Matos, A1

Other Studies

1 other study available for nabumetone and Urticaria

ArticleYear
Hypersensitivity to nabumetone: cross reactivity with naproxen.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2013, Volume: 111, Issue:1

    Topics: Adult; Angioedema; Butanones; Cross Reactions; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitor

2013